Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) has provided an announcement.
Extrawell Pharmaceutical Holdings Limited has issued a profit warning, indicating an expected loss between HK$450 million and HK$480 million for the six months ending September 30, 2025, compared to a profit in the same period in 2024. This anticipated loss is primarily due to an unrealized loss on the fair value of investments in convertible bonds, despite steady performance in its operating segments. The interim results are yet to be confirmed and will be published by the end of November 2025.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is involved in various segments, including the production of generic drugs and healthcare products, with a market focus on Hong Kong and potentially broader regions.
Average Trading Volume: 2,893,387
Technical Sentiment Signal: Buy
Current Market Cap: HK$221.8M
For detailed information about 0858 stock, go to TipRanks’ Stock Analysis page.